283 filings
8-K/A
ADXS
Ayala Pharmaceuticals, Inc.
19 Apr 24
Financial Statements and Exhibits
7:50am
8-K
ADXS
Ayala Pharmaceuticals, Inc.
3 Apr 24
Departure of Directors or Certain Officers
5:01pm
8-K
ADXS
Ayala Pharmaceuticals, Inc.
29 Mar 24
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
5:06pm
8-K
ADXS
Ayala Pharmaceuticals, Inc.
5 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
ADXS
Ayala Pharmaceuticals, Inc.
23 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K
m7wtcbvxnt1436o0
9 Feb 24
Unregistered Sales of Equity Securities
5:15pm
8-K
2z0jfy
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:51am
8-K/A
hnt9hdnv
3 Jan 24
Consolidated Financial Statements
4:18pm
8-K
wlhb7y1 ydz
20 Oct 23
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
4:31pm
8-K
ik7 qwyodvbsg
21 Sep 23
Entry into a Material Definitive Agreement
4:05pm
8-K
fi8hhntqspmw
1 Aug 23
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
9:00am
8-K
82l9uqpgin 0c13t8a
7 Apr 23
Changes in Registrant's Certifying Accountant
5:20pm
8-K/A
mhpnv5
6 Apr 23
Index to Financial Statements
5:24pm
8-K
rjy78r1q3qc
30 Jan 23
Amendments to Articles of Incorporation or Bylaws
6:02am
8-K
ldouogwa
25 Jan 23
Completion of Acquisition or Disposition of Assets
4:52pm
8-K
rsl423
13 Jan 23
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
56v5klgc
12 Jan 23
Other Events
4:05pm
8-K
3bbv88b
2 Dec 22
Entry into a Material Definitive Agreement
4:49pm
8-K
puzp4
19 Oct 22
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
4:31pm
8-K
33y5zq2jpoctovjej5
1 Jul 22
Departure of Directors or Certain Officers
4:05pm